Back |
home / stock / isco / isco message board
Subject | By | Source | When |
---|---|---|---|
MissionIR: International Stem Cell Corp. (ISCO) to Conduct Clinical Trial with One of the Worlds Lea | MissionIR | investorshangout | 12/23/2015 8:45:31 PM |
MissionIR: International Stem Cell Corporations (ISCO) Clinical Trials Vital to Halting Progression | MissionIR | investorshangout | 12/18/2015 12:46:20 AM |
MissionIR: International Stem Cell Corp. (ISCO) Gets Regulatory Green Light to Begin Clinical Trial | MissionIR | investorshangout | 12/14/2015 8:28:22 PM |
MissionIR: International Stem Cell Corp. (ISCO) Has a Broad Pipeline of Targets International Stem C | MissionIR | investorshangout | 12/08/2015 11:02:46 PM |
MissionIR: International Stem Cell Corp. (ISCO) to Launch New, Highly Lauded Skincare Product this H | MissionIR | investorshangout | 12/01/2015 9:16:45 PM |
News, Short Squeeze, Breakout and More Instantly...
International Stem Cell Corp Company Name:
ISCO Stock Symbol:
OTCMKTS Market:
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...